| Primary |
| Anxiety |
40.6% |
| Depression |
13.7% |
| Panic Disorder |
8.6% |
| Panic Attack |
7.6% |
| Nervous System Disorder |
5.1% |
| Hypertension |
3.6% |
| Generalised Anxiety Disorder |
3.0% |
| Blood Cholesterol Increased |
2.5% |
| Nervousness |
2.0% |
| Post-traumatic Stress Disorder |
2.0% |
| Bipolar Disorder |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastrointestinal Disorder |
1.5% |
| Agoraphobia |
1.0% |
| Blood Pressure High |
1.0% |
| Ex-smoker |
1.0% |
| Insomnia |
1.0% |
| Major Depression |
1.0% |
| Pain |
1.0% |
| Affective Disorder |
0.5% |
|
| Drug Ineffective |
15.0% |
| Tremor |
10.0% |
| Panic Attack |
7.5% |
| Death |
6.3% |
| Malaise |
6.3% |
| Weight Decreased |
6.3% |
| Fatigue |
5.0% |
| Hypersensitivity |
5.0% |
| Somnolence |
5.0% |
| Withdrawal Syndrome |
5.0% |
| Drug Effect Decreased |
3.8% |
| Insomnia |
3.8% |
| Premature Baby |
3.8% |
| Breast Cancer |
2.5% |
| Drug Dependence |
2.5% |
| Drug Intolerance |
2.5% |
| Drug Withdrawal Syndrome |
2.5% |
| Gastric Disorder |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Influenza |
2.5% |
|
| Secondary |
| Anxiety |
29.6% |
| Depression |
18.5% |
| Panic Attack |
10.9% |
| Panic Disorder |
9.7% |
| Hypertension |
3.8% |
| Blood Cholesterol Increased |
3.2% |
| Generalised Anxiety Disorder |
3.2% |
| Nervousness |
3.2% |
| Nervous System Disorder |
2.9% |
| Bipolar Disorder |
2.3% |
| Anxiety Disorder |
1.8% |
| Gastrointestinal Disorder |
1.8% |
| Product Used For Unknown Indication |
1.5% |
| Sleep Disorder |
1.5% |
| Attention Deficit/hyperactivity Disorder |
1.2% |
| Blood Pressure High |
1.2% |
| Post-traumatic Stress Disorder |
1.2% |
| Stress |
1.2% |
| Insomnia |
0.9% |
| Agoraphobia |
0.6% |
|
| Malaise |
11.9% |
| Withdrawal Syndrome |
11.9% |
| Tremor |
9.0% |
| Panic Attack |
7.5% |
| Somnolence |
7.5% |
| Anxiety |
4.5% |
| Depression |
4.5% |
| Drug Intolerance |
4.5% |
| Mental Disorder |
4.5% |
| Weight Decreased |
4.5% |
| Abdominal Discomfort |
3.0% |
| Activities Of Daily Living Impaired |
3.0% |
| Blood Cholesterol Increased |
3.0% |
| Drug Dependence |
3.0% |
| Drug Effect Decreased |
3.0% |
| Drug Ineffective |
3.0% |
| Drug Ineffective For Unapproved Indication |
3.0% |
| Fatigue |
3.0% |
| Feeling Abnormal |
3.0% |
| Hyperhidrosis |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.5% |
| Anxiety |
10.0% |
| Depression |
6.8% |
| Crohn's Disease |
5.6% |
| Drug Exposure During Pregnancy |
5.3% |
| Gastrooesophageal Reflux Disease |
4.9% |
| Insomnia |
4.0% |
| Sleep Disorder |
4.0% |
| Pain |
3.8% |
| Panic Attack |
3.5% |
| Drug Use For Unknown Indication |
3.0% |
| Hypertension |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Migraine |
2.6% |
| Bipolar Disorder |
2.5% |
| Hypersensitivity |
2.5% |
| Asthma |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Blood Cholesterol Increased |
1.5% |
| Convulsion |
1.5% |
|
| Weight Increased |
12.3% |
| Type 2 Diabetes Mellitus |
9.6% |
| Vomiting |
9.6% |
| Oedema Peripheral |
5.5% |
| Pulmonary Embolism |
5.5% |
| Suicidal Ideation |
5.5% |
| Tremor |
5.5% |
| Nausea |
4.1% |
| Pain In Extremity |
4.1% |
| Pancreatitis |
4.1% |
| Product Quality Issue |
4.1% |
| Urinary Tract Infection |
4.1% |
| Ventricular Fibrillation |
4.1% |
| Ventricular Septal Defect |
4.1% |
| Weight Decreased |
4.1% |
| Completed Suicide |
2.7% |
| Conversion Disorder |
2.7% |
| Depression |
2.7% |
| Drug Ineffective |
2.7% |
| Dyspnoea |
2.7% |
|
| Interacting |
| Staphylococcal Infection |
66.7% |
| Panic Disorder |
33.3% |
|
| Staphylococcal Infection |
100.0% |
|
